PDCD1 and neoplasm: (44) compared peripheral blood mononuclear cells (PBMCs), tumor biopsy specimens, and biopsies from sites of immune-associated skin toxicity in non-small cell lung cancer patients treated with anti-PD-1 through T-cell receptor sequencing (TCRseq).